Cardiosource
Marc S. Sabatine, Eugene Braunwald
Thus, in the early management of patients with ACS, it may not be sufficient simply to lower the level of low-density lipoprotein cholesterol, as all three statins did in these trials; the goal also must be to reduce inflammation, as reflected by lowering CRP.
No comments:
Post a Comment